Phenotype of the Cyp1a1/1a2/1b1(-/-) triple-knockout mouse

被引:55
|
作者
Dragin, Nadine [1 ,2 ]
Shi, Zhanquan [1 ,2 ]
Madan, Rajat [3 ]
Karp, Christopher L. [3 ]
Sartor, Maureen A. [1 ,2 ]
Chen, Chi [4 ]
Gonzalez, Frank J. [4 ]
Nebert, Daniel W. [1 ,2 ]
机构
[1] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA
[3] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH USA
[4] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1124/mol.108.045658
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Crossing the Cyp1a1/1a2(-/-) double- knockout mouse with the Cyp1b1(-/-) single- knockout mouse, we generated the Cyp1a1/1a2/1b1(-/-) triple-knockout mouse. In this triple-knockout mouse, statistically significant phenotypes (with incomplete penetrance) included slower weight gain and greater risk of embryolethality before gestational day 11, hydrocephalus, hermaphroditism, and cystic ovaries. Oral benzo[a] pyrene (BaP) daily for 18 days in the Cyp1a1/1a2(-/-) produced the same degree of marked immunosuppression as seen in the Cyp1a1(-/-) mouse; we believe this reflects the absence of intestinal CYP1A1. Oral BaP-treated Cyp1a1/1a2/1b1(-/-) mice showed the same "rescued" response as that seen in the Cyp1a1/1b1(-/-) mouse; we believe this reflects the absence of CYP1B1 in immune tissues. Urinary metabolite profiles were dramatically different between untreated triple-knockout and wild-type; principal components analysis showed that the shifts in urinary metabolite patterns in oral BaP-treated triple-knockout and wild-type mice were also strikingly different. Liver microarray cDNA differential expression (comparing triple-knockout with wild-type) revealed at least 89 genes up- and 62 genes down-regulated (P-value <= 0.00086). Gene Ontology "classes of genes" most perturbed in the untreated triple-knockout (compared with wild-type) include lipid, steroid, and cholesterol biosynthesis and metabolism; nucleosome and chromatin assembly; carboxylic and organic acid metabolism; metal-ion binding; and ion homeostasis. In the triple-knockout compared with the wild-type mice, response to zymosan-induced peritonitis was strikingly exaggerated, which may well reflect down-regulation of Socs2 expression. If a single common molecular pathway is responsible for all of these phenotypes, we suggest that functional effects of the loss of all three Cyp1 genes could be explained by perturbations in CYP1-mediated eicosanoid production, catabolism and activities.
引用
收藏
页码:1844 / 1856
页数:13
相关论文
共 50 条
  • [41] In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1
    Rochat, Bertrand
    Zoete, Vincent
    Grosdidier, Aurelien
    von Gruenigen, Sandrine
    Marull, Marc
    Michielin, Olivier
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (02) : 103 - 118
  • [42] Polymorphic Variation of CYP1A1 and CYP1B1 Genes in a Haryana Population
    Giri, Shiv Kumar
    Yadav, Anita
    Kumar, Anil
    Dev, Kapil
    Gulati, Sachin
    Gupta, Ranjan
    Aggarwal, Neeraj
    Gautam, Sanjeev Kumar
    BIOCHEMICAL GENETICS, 2013, 51 (11-12) : 853 - 864
  • [43] Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin
    Chang, Thomas K. H.
    Chen, Jie
    Yang, Guixiang
    Yeung, Eugene Y. H.
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (01) : 55 - 64
  • [44] Polymorphic Variation of CYP1A1 and CYP1B1 Genes in a Haryana Population
    Shiv Kumar Giri
    Anita Yadav
    Anil Kumar
    Kapil Dev
    Sachin Gulati
    Ranjan Gupta
    Neeraj Aggarwal
    Sanjeev Kumar Gautam
    Biochemical Genetics, 2013, 51 : 853 - 864
  • [45] CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers
    Habano, Wataru
    Gamo, Toshie
    Suga, Tamotsu
    Otsuka, Koki
    Wakabayashi, Go
    Ozawa, Shogo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (04) : 1085 - 1091
  • [46] Expression profile of CYP1A1 and CYP1B1 enzymes in endometrial tumors
    Spyrou, Ioannis
    Sifakis, Stavros
    Ploumidis, Achilles
    Papalampros, Alexandros E.
    Felekouras, Evangellos
    Tsatsakis, Aristidis M.
    Spandidos, Demetrios A.
    Androutsopoulos, Vasilis P.
    TUMOR BIOLOGY, 2014, 35 (10) : 9549 - 9556
  • [47] Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1
    Shimada, T
    Yamazaki, H
    Foroozesh, M
    Hopkins, NE
    Alworth, WL
    Guengerich, FP
    CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (09) : 1048 - 1056
  • [48] CYP1A1/CYP1A2 polymorphisms and colorectal cancer
    Ozhan, Gul
    Mutur, Mine
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [49] Involvement of cytochrome b(5) in the metabolism of tetrachlorobiphenyls catalyzed by CYP2B1 and CYP1A1
    Matsusue, K
    Ariyoshi, N
    Oguri, K
    Koga, N
    Yoshimura, H
    CHEMOSPHERE, 1996, 32 (03) : 517 - 523
  • [50] A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1,-1A2 and-1B1 by preventing activation of the aryl hydrocarbon receptor
    Sienkiewicz, Pawel
    Ciolino, Henry P.
    Leslie, Benjamin J.
    Hergenrother, Paul J.
    Singletary, Keith
    Yeh, Grace Chao
    CARCINOGENESIS, 2007, 28 (05) : 1052 - 1057